422 related articles for article (PubMed ID: 31616427)
21. Elevated titers of anti-thyroperoxidase antibodies in patients with multiple system atrophy: a pilot study.
Shihman B; Giladi N; Bleiberg M; Rosenberg A; Korczyn AD; Gurevich T
Clin Neurol Neurosurg; 2013 Nov; 115(11):2348-50. PubMed ID: 24063975
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
[TBL] [Abstract][Full Text] [Related]
23. Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.
Rabenstein M; Besong Agbo D; Wolf E; Dams J; Nicolai M; Roeder A; Bacher M; Dodel RC; Noelker C
Neurosci Lett; 2019 Jun; 704():181-188. PubMed ID: 30954607
[TBL] [Abstract][Full Text] [Related]
24. α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
Yanamandra K; Gruden MA; Casaite V; Meskys R; Forsgren L; Morozova-Roche LA
PLoS One; 2011 Apr; 6(4):e18513. PubMed ID: 21541339
[TBL] [Abstract][Full Text] [Related]
25. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.
Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C
Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301
[TBL] [Abstract][Full Text] [Related]
26. Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.
Horvath I; Iashchishyn IA; Forsgren L; Morozova-Roche LA
ACS Chem Neurosci; 2017 Jun; 8(6):1170-1176. PubMed ID: 28263550
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
[TBL] [Abstract][Full Text] [Related]
28. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.
Valera E; Spencer B; Fields JA; Trinh I; Adame A; Mante M; Rockenstein E; Desplats P; Masliah E
Acta Neuropathol Commun; 2017 Jan; 5(1):2. PubMed ID: 28057080
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated α-Synuclein Deposits in Cutaneous Nerves of Early Parkinsonism.
Nolano M; Caporaso G; Manganelli F; Stancanelli A; Borreca I; Mozzillo S; Tozza S; Dubbioso R; Iodice R; Vitale F; Koay S; Vichayanrat E; da Silva FV; Santoro L; Iodice V; Provitera V
J Parkinsons Dis; 2022; 12(8):2453-2468. PubMed ID: 36373295
[TBL] [Abstract][Full Text] [Related]
30. The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
Albus A; Kronimus Y; Burg-Roderfeld M; van der Wurp H; Willbold D; Ziehm T; Dodel R; Ross JA
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759704
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
Gibbons C; Wang N; Rajan S; Kern D; Palma JA; Kaufmann H; Freeman R
Neurology; 2023 Apr; 100(15):e1529-e1539. PubMed ID: 36657992
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein in Parkinson's disease: causal or bystander?
Riederer P; Berg D; Casadei N; Cheng F; Classen J; Dresel C; Jost W; Krüger R; Müller T; Reichmann H; Rieß O; Storch A; Strobel S; van Eimeren T; Völker HU; Winkler J; Winklhofer KF; Wüllner U; Zunke F; Monoranu CM
J Neural Transm (Vienna); 2019 Jul; 126(7):815-840. PubMed ID: 31240402
[TBL] [Abstract][Full Text] [Related]
33. Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference.
Ishii R; Tokuda T; Tatebe H; Ohmichi T; Kasai T; Nakagawa M; Mizuno T; El-Agnaf OM
PLoS One; 2015; 10(4):e0123162. PubMed ID: 25849645
[TBL] [Abstract][Full Text] [Related]
34. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
[TBL] [Abstract][Full Text] [Related]
35. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
Kronimus Y; Albus A; Balzer-Geldsetzer M; Straub S; Semler E; Otto M; Klotsche J; Dodel R; ; Mengel D
PLoS One; 2016; 11(11):e0164953. PubMed ID: 27802290
[TBL] [Abstract][Full Text] [Related]
36. Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of α-synuclein in multiple system atrophy.
Kiely AP; Miners JS; Courtney R; Strand C; Love S; Holton JL
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):347-360. PubMed ID: 29993134
[TBL] [Abstract][Full Text] [Related]
37. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
38. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
[TBL] [Abstract][Full Text] [Related]
40. Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.
Maetzler W; Apel A; Langkamp M; Deuschle C; Dilger SS; Stirnkorb JG; Schulte C; Schleicher E; Gasser T; Berg D
PLoS One; 2014; 9(2):e88604. PubMed ID: 24586351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
